The current market cap is $75 million. Take $10 billion and divide it by $75 Million and then multiply that number times the pps.
Oh, it seems unrealistic, that is because it is totally unrealistic.
Now, I really do think they will sell at some point, for $$$ based on MANF. I have no idea when that will happen.
Any transaction based on Lympro will not take place for at least two years, because there is no market for that outside of POSSIBLE research, if the test is accepted. IOW, it has to beat AMVID.
If it does beat AMVID, I will not be surprised, but it will mean that the data got better, which does not happen too often.
Personally, I am getting ready to sell on the day of the Copenhagen conference. Historically, that is an excellent time to sell AMBS for obvious reasons.
The fact that GC feels he needs to have a twitter conference in order to get the penny investors ready for the upcoming data tells me a LOT.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill